share_log

昭衍新藥:2022中期報告

JOINN: 2022 Interim Report

Sep 23, 2022 05:12
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more